N.Y. Lawmakers Oppose Ban on Race-Day Salix
Tom LaMarra
June 13, 2012
Two New York senators announced June 12 that they do not support a ban on race-day Salix administration.
Two New York senators announced June 12 that they do not support a ban on race-day Salix administration.
The measure would ban the use of furosemide on race-day in graded and listed stakes over a three-year period.
The AGSC supports a ban on all race-day medication in graded stakes race for 2-year-old Thoroughbreds.
Roughly 15 individuals commented on the KHRC Salix phase-out proposal, with only one in support of the measure
The Salix debate will continue in early June when the KHRC holds a town hall meeting on the topic.
The KHRC will discuss a possible three-year phase-out of race-day furosemide in graded and listed stakes.
Salix is a medication used to prevent exercise-induced pulmonary hemorrhaging, also known as bleeding.
The witnesses all told Congress they don’t believe race-day medication has a place in Thoroughbred racing.
A rundown of respiratory diseases commonly observed in performance horses.
Panelists said there is no scientific evidence supporting a ban on the use of furosemide on race day.
Furosemide, known as Salix, will be discussed Jan. 14 during the National HBPA Medication Committee forum.
The respiratory system can be a major cause of poor performance or premature retirement from competition.
Could your horse have a respiratory disease? Here’s how your vet will find out.
There is a decided split between trainers and breeders on the issue of race day furosemide in Thoroughbreds.
The meeting began with several presentations on furosemide and EIPH, the condition the medication treats.
The Race Day Medication Committee is debating whether therapeutic medications such as Salix should be banned.
Stay on top of the most recent Horse Health news with
